ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Short Interest Update

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) was the target of a significant increase in short interest in December. As of December 15th, there was short interest totalling 10,300 shares, an increase of 22.6% from the November 30th total of 8,400 shares. Based on an average daily trading volume, of 12,700 shares, the days-to-cover ratio is presently 0.8 days.

ProShares UltraShort Nasdaq Biotechnology Trading Up 2.1 %

NASDAQ BIS traded up $0.36 on Friday, hitting $17.85. 5,573 shares of the stock traded hands, compared to its average volume of 14,111. The stock has a 50-day moving average of $16.32 and a 200 day moving average of $15.73. ProShares UltraShort Nasdaq Biotechnology has a twelve month low of $14.05 and a twelve month high of $21.10.

ProShares UltraShort Nasdaq Biotechnology Increases Dividend

The company also recently declared a dividend, which will be paid on Tuesday, December 31st. Shareholders of record on Monday, December 23rd will be paid a $0.2064 dividend. The ex-dividend date of this dividend is Monday, December 23rd. This is a positive change from ProShares UltraShort Nasdaq Biotechnology’s previous dividend of $0.15.

Institutional Investors Weigh In On ProShares UltraShort Nasdaq Biotechnology

A hedge fund recently bought a new stake in ProShares UltraShort Nasdaq Biotechnology stock. Jane Street Group LLC bought a new position in shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 10,520 shares of the company’s stock, valued at approximately $158,000. Jane Street Group LLC owned approximately 4.78% of ProShares UltraShort Nasdaq Biotechnology as of its most recent filing with the Securities and Exchange Commission (SEC).

About ProShares UltraShort Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.